Boosted by new drugs, Boehringer shrugs off patent expiry
pharmaphorum media | April 06, 2017
Formerly the company’s chief finance officer, Hubertus von Baumbach has been in post since last June when he took over from Andreas Barner, and is overseeing strong growth.